Indications for: BOOSTRIX

Diphtheria, tetanus, and pertussis booster immunization in patients ≥10 years of age. Immunization during the 3rd trimester of pregnancy to prevent pertussis in infants <2 months of age.

Adults and Children:

Booster immunization: <10yrs: not recommended. ≥10yrs (≥5yrs after last childhood DTwP or DTaP or adult Td vaccine): 0.5mL IM once into deltoid muscle.  Immunization during 3rd trimester of pregnancy: 0.5mL IM once into deltoid muscle.

BOOSTRIX Contraindications:

Encephalopathy within 7 days after previous DTaP or DTwP vaccination.

BOOSTRIX Warnings/Precautions:

Guillain-Barre syndrome (within 6 weeks) after previous tetanus toxoid vaccine: see full labeling. Progressive or unstable neurologic disorders (eg, cerebrovascular events, acute encephalopathic conditions). Previous Arthus-type hypersensitivity reaction: not recommended until ≥10yrs after prior dose of tetanus toxoid-containing vaccine. Immunosuppressed. Have epinephrine available. Latex allergy. Pregnancy: see full labeling. Nursing mothers.

BOOSTRIX Classification:


BOOSTRIX Interactions:

Concomitant vaccines: see full labeling. Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response.

Adverse Reactions:

Local reactions (eg, pain, redness, swelling), fever, headache, fatigue, GI upset.


Register pregnant patients exposed to Boostrix by calling (888) 452-9622. Report adverse events to VAERS by calling (800) 822-7967.

How Supplied:

Single-dose vials or prefilled syringes (without needles)—10